Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination

Background Highly sensitive cardiac troponin assays (hs-cTn) are not available as point-of-care (POC) measurements. As rapid testing cannot be achieved at the expense of clinical performance, there is an urgent need to develop and rigorously validate POC hs-cTn. Konica Minolta (KM) has recently developed a surface plasmon-field enhanced fluorescence spectroscopy-based POC hs-cTn I system. Methods We validated the analytical characteristics of the KM POC system according to the international guidelines. Results Limit of blank (LoB) and limit of detection (LoD) were 0.35 and 0.62 ng/L, respectively, hs-cTn I concentrations corresponding to a total CV of 20%, 10% and 5% were 1.5, 3.9 and 11.0 ng/L, respectively. Method comparison studies showed that KM calibration was successfully traced to higher-order references. Limit of quantitation (LoQ), i.e. the hs-cTn I concentration having a total error of measurement of ≤34%, was 10.0 ng/L. The upper reference limit (URL) for 600 healthy blood donors was calculated at 12.2 ng/L (90% confidence interval [CI]: 9.2-39.2), while sex-partitioned URLs were 20.6 (males) and 10.7 ng/L (females), respectively (p < 0.0001). KM assay measured hs-cTn I concentrations >LoD in 65.7% of all reference individuals, in 76.7% of males and in 54.7% of females, respectively. Conclusions The KM system joins the characteristics of POC systems to the analytical performance of hs-cTn.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:58

Enthalten in:

Clinical chemistry and laboratory medicine - 58(2019), 1 vom: 18. Dez., Seite 138-145

Sprache:

Englisch

Beteiligte Personen:

Braga, Federica [VerfasserIn]
Aloisio, Elena [VerfasserIn]
Panzeri, Andrea [VerfasserIn]
Nakagawa, Takahito [VerfasserIn]
Panteghini, Mauro [VerfasserIn]

Links:

Volltext

Themen:

High sensitivity troponin
Journal Article
Method evaluation
Point of care testing
Troponin I
Validation Study

Anmerkungen:

Date Completed 04.09.2020

Date Revised 13.09.2021

published: Print

Citation Status MEDLINE

doi:

10.1515/cclm-2019-0801

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM302286152